Prodcut name: Monobenzone
Specification: 99%
Appearance: White Powder
CAS: 103-16-2
Mesh size: 80 Mesh
Grade: Pharmaceutical
Brand Name: PRIUS
Test Method: HPLC
Monobenzone is an FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some overweight adults with a weight-related medical problem, or obese adults, lose weight and keep it off.
Monobenzone a serotonin 2C receptor agonist. It hasbeen shown to decrease food consumption and promote sa tiety by selectivelyactivating serotonin 2C receptors in the brain.
Monobenzone is specifically indicated as an adjunct to a reduced-calorie diet andincreased physical activity for chronic weight management in clinically obeseadults (BMI of 30 kg/m2 or greater) and overweight adults (BMI of 27 kg/m2 orgreater) with at least one weight-related comorbid condition.
Monobenzone is supplied as a tablet designed for oral administration. The recommendeddose is one 10mg tablet twice daily.
1.Monobenzone Powder is a compound used as a topical drug for medical depigmentation.
2.The topical application of monobenzone powder in animals decreases the excretion of melanin from melanocytes.
The same action is thought to be responsible for the depigmenting effect of the drug in humans.
3.Monobenzone Powder may cause destruction of melanocytes and permanent depigmentation.
4.The histology of the skin after depigmentation with topical monobenzone powder is the same as that seen in vitiligo.
5.The epidermis is normal except for the absence of identifiable melanocytes.